Comparison

Satralizumab European Partner

Manufacturer MedChem Express
Category
Type Biosimilars
Specific against other
Amount 10 mg
Item no. HY-P99112-10mg
CASRN 1535963-91-7
eClass 6.1 32160702
eClass 9.0 42030590
Available
Product Description
Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research[1][2].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Manufacturers Applications
COVID-19-immunoregulation
Molecular Weight
N/A
Clinical Information
Launched
Solubility
H2O
Isoform
IL-6
Pathway
Immunology/Inflammation
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close